Cargando…

Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment

PURPOSE: Gene transduction using adenoviral vectors is an important research tool. To assess and optimize this technique for glaucoma research, we characterized green fluorescent protein (GFP) expression in the mouse eye after intraocular injection of adenoviral vector encoding GFP (Ad5.CMV-GFP) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Millar, J. Cameron, Pang, Iok-Hou, Wang, Wan-Heng, Wang, Yu, Clark, Abbot F.
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267727/
https://www.ncbi.nlm.nih.gov/pubmed/18246028
_version_ 1782151650608152576
author Millar, J. Cameron
Pang, Iok-Hou
Wang, Wan-Heng
Wang, Yu
Clark, Abbot F.
author_facet Millar, J. Cameron
Pang, Iok-Hou
Wang, Wan-Heng
Wang, Yu
Clark, Abbot F.
author_sort Millar, J. Cameron
collection PubMed
description PURPOSE: Gene transduction using adenoviral vectors is an important research tool. To assess and optimize this technique for glaucoma research, we characterized green fluorescent protein (GFP) expression in the mouse eye after intraocular injection of adenoviral vector encoding GFP (Ad5.CMV-GFP) and evaluated the effect of anti-CD40L antibody administration on GFP expression. METHODS: Mice were injected with Ad5.CMV-GFP intracamerally (IC) or intravitreally (IVT) with or without anti-CD40L antibody treatment. GFP expression was assessed by in vivo fluorescence intensity with a standardized grading scale. Location of expression was analyzed histologically by fluorescence microscopy. RESULTS: Intraocular injection of Ad5.CMV-GFP induced titer-dependent expression of GFP in the anterior segment. In vivo fluorescence was detectable but low after IC injection. After IVT injection, fluorescence in the eye peaked at days 4–7 with a fluorescence grade of 3.0 ±0.0 (mean ±SEM, n=6; injection with 1x10(8) pfu vector). After day 7, GFP expression declined significantly. Treatment with anti-CD40L antibody increased fluorescence intensity after IC injection, and prolonged GFP expression in the IVT group. At day 43, fluorescence grades of the IVT group were 2.8 ±0.7 (with anti-CD40L) and 1.2 ±0.6 (without antibody). Three-Way ANOVA confirmed that GFP expression was significantly higher in the anti-CD40L than the no antibody group (p=0.013), significantly higher in the IVT than the IC group (p=0.003), and significantly higher in the high viral titer (1x10(8) pfu) than the low titer (1x10(7) pfu) group (p=0.010). Fluorescence microscopic examination of cross-sections of eyes indicated GFP expression in the trabecular meshwork (TM), corneal endothelium, and sporadically iris, ciliary body and lens epithelium. CONCLUSIONS: Intraocular injection of Ad5.CMV-GFP induced GFP expression in the mouse anterior segment, including the TM. Expression was more prominent after IVT injection than IC injection. Anti-CD40L antibody treatment increased both intensity and duration of GFP expression. These findings provide important and practical means to improve duration and efficiency of adenovirus-mediated transgene expression in the eye.
format Text
id pubmed-2267727
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-22677272008-03-20 Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment Millar, J. Cameron Pang, Iok-Hou Wang, Wan-Heng Wang, Yu Clark, Abbot F. Mol Vis Research Article PURPOSE: Gene transduction using adenoviral vectors is an important research tool. To assess and optimize this technique for glaucoma research, we characterized green fluorescent protein (GFP) expression in the mouse eye after intraocular injection of adenoviral vector encoding GFP (Ad5.CMV-GFP) and evaluated the effect of anti-CD40L antibody administration on GFP expression. METHODS: Mice were injected with Ad5.CMV-GFP intracamerally (IC) or intravitreally (IVT) with or without anti-CD40L antibody treatment. GFP expression was assessed by in vivo fluorescence intensity with a standardized grading scale. Location of expression was analyzed histologically by fluorescence microscopy. RESULTS: Intraocular injection of Ad5.CMV-GFP induced titer-dependent expression of GFP in the anterior segment. In vivo fluorescence was detectable but low after IC injection. After IVT injection, fluorescence in the eye peaked at days 4–7 with a fluorescence grade of 3.0 ±0.0 (mean ±SEM, n=6; injection with 1x10(8) pfu vector). After day 7, GFP expression declined significantly. Treatment with anti-CD40L antibody increased fluorescence intensity after IC injection, and prolonged GFP expression in the IVT group. At day 43, fluorescence grades of the IVT group were 2.8 ±0.7 (with anti-CD40L) and 1.2 ±0.6 (without antibody). Three-Way ANOVA confirmed that GFP expression was significantly higher in the anti-CD40L than the no antibody group (p=0.013), significantly higher in the IVT than the IC group (p=0.003), and significantly higher in the high viral titer (1x10(8) pfu) than the low titer (1x10(7) pfu) group (p=0.010). Fluorescence microscopic examination of cross-sections of eyes indicated GFP expression in the trabecular meshwork (TM), corneal endothelium, and sporadically iris, ciliary body and lens epithelium. CONCLUSIONS: Intraocular injection of Ad5.CMV-GFP induced GFP expression in the mouse anterior segment, including the TM. Expression was more prominent after IVT injection than IC injection. Anti-CD40L antibody treatment increased both intensity and duration of GFP expression. These findings provide important and practical means to improve duration and efficiency of adenovirus-mediated transgene expression in the eye. Molecular Vision 2008-01-09 /pmc/articles/PMC2267727/ /pubmed/18246028 Text en Copyright © 2008 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Millar, J. Cameron
Pang, Iok-Hou
Wang, Wan-Heng
Wang, Yu
Clark, Abbot F.
Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment
title Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment
title_full Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment
title_fullStr Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment
title_full_unstemmed Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment
title_short Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment
title_sort effect of immunomodulation with anti-cd40l antibody on adenoviral-mediated transgene expression in mouse anterior segment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267727/
https://www.ncbi.nlm.nih.gov/pubmed/18246028
work_keys_str_mv AT millarjcameron effectofimmunomodulationwithanticd40lantibodyonadenoviralmediatedtransgeneexpressioninmouseanteriorsegment
AT pangiokhou effectofimmunomodulationwithanticd40lantibodyonadenoviralmediatedtransgeneexpressioninmouseanteriorsegment
AT wangwanheng effectofimmunomodulationwithanticd40lantibodyonadenoviralmediatedtransgeneexpressioninmouseanteriorsegment
AT wangyu effectofimmunomodulationwithanticd40lantibodyonadenoviralmediatedtransgeneexpressioninmouseanteriorsegment
AT clarkabbotf effectofimmunomodulationwithanticd40lantibodyonadenoviralmediatedtransgeneexpressioninmouseanteriorsegment